SCHEMBL22820870

SCHEMBL22820870

C/C=C(/CCN)C(C)(C)C

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.30
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19356146 0.77 — —
SCHEMBL10643014 0.74 CES2 (0.32) —
SCHEMBL10643011 0.74 CES2 (0.32) —
SCHEMBL18737291 0.72 — —
SCHEMBL13370623 0.72 — —
SCHEMBL23265970 0.69 TSHR (0.33) ALDH1A1TSHR
SCHEMBL19424071 0.69 — —
SCHEMBL8931299 0.67 — —
SCHEMBL19177004 0.67 — —
SCHEMBL25973370 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257549-A2 COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES CHEMOCENTRYX, INC. (US) 2020-12-24 — — WO disclosed
Send feedback